Pharmabiz

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint: Basel Wednesday, September 9, 2026, 09:00 Hrs [IST] No ...
Pharmabiz

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition: Our Bureau, Bengaluru Wednesday, September 9, 2026, 10:00 Hrs [IST] Leucine Rich Bio, South Asia’ ...
Pharmabiz

BMJ Research Forum South Asia 2026 calls for research that changes lives

BMJ Research Forum South Asia 2026, was held in New Delhi under the theme “Driving Real-World Impact from Health Research in ...
Pharmabiz

Karnataka FSDA bags Certificate of Appreciation for regulatory excellence

Karnataka FSDA bags Certificate of Appreciation for regulatory excellence: Our Bureau, Bengaluru Tuesday, September 8, 2026, 17:15 Hrs [IST] The Karnataka Food Safety and Drug Adm ...
Pharmabiz

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026: Our Bureau, Chennai Tuesday, September 8, 2026, 14:20 ...
Pharmabiz

Indian pharmaceutical market clocked 10.7% growth in August driven by price realization & Mounjaro surge

Indian pharmaceutical market clocked 10.7% growth in August driven by price realization & Mounjaro surge: Peethaambaran Kunnathoor, Chennai Wednesday, September 9, 2026, 08:00 Hrs ...
Pharmabiz

Expert asks NPPA to fix ceiling price for two early-stage breast cancer drugs abemaciclib and ribociclib

Expert asks NPPA to fix ceiling price for two early-stage breast cancer drugs abemaciclib and ribociclib: Our Bureau, New Delhi Wednesday, September 9, 2026, 08:00 Hrs [IST] The C ...
Pharmabiz

Fire safety must be embedded in healthcare design, not treated as an afterthought: Experts at FSIE 2026

Fire safety must be embedded in healthcare design, not treated as an afterthought: Experts at FSIE 2026: Shardul Nautiyal, Mumbai Wednesday, September 9, 2026, 08:00 Hrs [IST] Fir ...
Pharmabiz

Panel asks health ministry to mandate systematic pharmacoeconomic studies for widely prescribed Ayush drugs

The Department-related Parliamentary Standing Committee on Health and Family Welfare has recommended to the ministry of health to mandate systematic pharmacoeconomic studies for all widely prescribed ...
Pharmabiz

India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes

India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes: Nandita Vijayasimha, Bengaluru Wednesday, September 9, 2026, 08:00 Hrs [ ...
Opinion
PharmabizOpinion

A LAUDABLE INITIATIVE ON AMR

Obviously, it is a well thought out initiative as drug resistance cannot not be solved by guidelines alone. It can be solved at the patient's bedside, one clinical decision at a time. Those decisions ...
Pharmabiz

Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification

Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification: Bagsværd, Denm ...